Nanalysis Scientific Corp.

Good afternoon, ladies and gentlemen, and welcome to the Analysis Scientific Q1 2025 conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call we require immediate assistance, please press star zero for the operator. This call is being recorded on Wednesday, May 28, 2025. And I would now like to turn the conference over to Mr. Matthew Salinger, Investor Relations, please go ahead.

Thank you, Operator, and welcome everyone to the Analysis Scientific's first quarter 2025 conference call.

Before we begin, I would like to remind everyone that our remarks and responses to your questions today will contain forward-looking statements that are based on the current expectations of management. These assumptions involve inherent risks and uncertainties that could cause actual results to differ materially from our responses. Certain material factors and assumptions were considered and applied in making the forward-looking statements. These risk factors are included in our filings for the year ended December 31st, 2024. Forward-looking statements on this call may include but are not limited to statements and comments with respect to future growth of the company's business, the ability to graduate to a senior exchange, the company's acquisition strategy, the ability to develop future products, and the possible associated results. The company's actual performance and financial results in the future could differ materially from any estimates or projections of future performance implied by the forward-looking statements. The forward-looking statements made on this call speak only as of today, and Analysis Scientific assumes no obligation to update any forward-looking information as a result of new information, future events, or otherwise, except as expressly required by applicable law. For additional information, I encourage everyone to review our public filings and press releases, which are posted on the CDAR filing system at www.sedarplus.ca. So on the call with me today are NANALYSIS founder and CEO, Mr. Sean Krakiewski, and NANALYSIS CFO, Mr. Randall McRae. So with that, I would like to turn the call over to NANALYSIS CFO, Randall McRae. Randall?